Viral hepatitis: new hepatitis C therapies-a medical pick and mix.
Katrina
K
Ray
D000813:Anilides / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use*; D005260:Female; D005449:Fluorenes / Q000627:therapeutic use*; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D047028:Macrocyclic Compounds / Q000627:therapeutic use*; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D014498:Uracil / Q000031:analogs & derivatives*; D014542:Uridine Monophosphate / Q000031:analogs & derivatives*
D000813:Anilides; D000998:Antiviral Agents; D001562:Benzimidazoles; D002219:Carbamates; D005449:Fluorenes; D047028:Macrocyclic Compounds; D013449:Sulfonamides; D012254:Ribavirin; D014498:Uracil; D014542:Uridine Monophosphate; D019438:Ritonavir